Completed PHASE1 INTERVENTIONAL 3-arm NCT01380431

A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study

Randomized, Open-label, Three Treatment Crossover Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study

Sponsor: Par Pharmaceutical, Inc.

Conditions To Determine Bioequivalence Under Fed Conditions

Interventions Lisinopril lisinopril

Updated 6 times since 2017 Last updated: Jun 22, 2011 Started: Aug 31, 1999 Primary completion: Oct 31, 1999 Completion: Oct 31, 1999

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01380431, this PHASE1 trial focuses on To Determine Bioequivalence Under Fed Conditions and remains completed. Sponsored by Par Pharmaceutical, Inc., it has been updated 6 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Aug 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Par Pharmaceutical, Inc.
PharmaKinetics Laboratories Inc.

Data source: Par Pharmaceutical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States